Focused Hedge Funds News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Focused hedge funds. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Focused Hedge Funds Today - Breaking & Trending Today

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q3 2023 Earnings Call Transcript

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q3 2023 Earnings Call Transcript November 14, 2023 Acurx Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.23952, expectations were $-0.28. Operator: Ladies and gentlemen, good morning, and welcome to the Acurx Pharmaceuticals Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. A brief […] ....

United States , Kevin Garey , Dave Luci , Robert Deluccia , Bob Deluccia , Robert Shawah , Rob Shawah , David Luci , University Of Houston College Pharmacy , Microbial Resistance Congress , European Medicines Agency , International Conference On Molecular Biology , Exchange Commission , World Anti Microbial Resistance Congress , Executive Chairman , Gram Positive Bacterial Infections , Houston College , Principal Investigator , Gram Positive Selective Spectrum Activity , Secondary Analysis , New Antimicrobials , Gram Positive Bacterial , International Conference , Molecular Biology , Vitro Biofilm Studies , Comparator Antibiotics ,

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q3 2023 Earnings Call Transcript

Operator: Ladies and gentlemen, good morning, and welcome to the Acurx Pharmaceuticals Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. ....

United States , Rob Shawah , Ed Arce , Kevin Garey , Michael Okunewitch , Dave Luci , David Luci , Thomas Yip , Robert Deluccia , Jason Mccarthy , Robert Shawah , Bob Deluccia , International Conference On Molecular Biology , Exchange Commission , European Medicines Agency , University Of Houston College Pharmacy , Maxim Group , Microbial Resistance Congress , Acurx Pharmaceuticals Third Quarter , Acurx Pharmaceuticals Inc , Acurx Pharmaceuticals , Call Transcript November , Chief Financial , Executive Chairman , World Anti Microbial Resistance Congress , Gram Positive Bacterial Infections ,

Biora Therapeutics, Inc. (NASDAQ:BIOR) Q3 2023 Earnings Call Transcript

Biora Therapeutics, Inc. (NASDAQ:BIOR) Q3 2023 Earnings Call Transcript November 13, 2023 Biora Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-4.89 EPS, expectations were $-0.93. Operator: Greetings and welcome to the Biora Therapeutics Third Quarter 2023 earnings call. At this time, all participants are in a listen only mode. A brief question-and-answer session […] ....

Adi Mohanty , Joe Pantginis , Ann Arbor , Focused Hedge Funds , Chuck Pedala , Phase 1 Clinical Trial , Perator Instructions , Forward Looking Statements , R Mohanty , Adi Mohanty ,

Henry Schein, Inc. (NASDAQ:HSIC) Q3 2023 Earnings Call Transcript

Henry Schein, Inc. (NASDAQ:HSIC) Q3 2023 Earnings Call Transcript November 13, 2023 Henry Schein, Inc. misses on earnings expectations. Reported EPS is $1.32 EPS, expectations were $1.33. Operator: Good morning, ladies and gentlemen, and welcome to Henry Schein’s Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, […] ....

United States , Stanley Bergman , Global Technology , Strategic Advisory Council , Henry Schein One , Large Practice Sales , Schein One , Dentrix Ascend , Advisory Council , Global Dental , North America , Best Coffee According , Focused Hedge Funds , Henry Schein , Stanley Bergman , Graham Stanley , Financial Results , North American , Son South , Business Performance , Investor Relations Website ,

Henry Schein, Inc. (NASDAQ:HSIC) Q3 2023 Earnings Call Transcript

Operator: Good morning, ladies and gentlemen, and welcome to Henry Schein s Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. ....

New Zealand , United States , Biohorizons Camlog , Stanley Bergman , Elizabeth Anderson , Henry Schein , Graham Stanley , Strategic Advisory Council , Exchange Commission , Global Technology , Henry Schein Inc , Call Transcript November , Third Quarter , Vice President , Investor Relations , Strategic Financial Project , Chief Executive Officer , Iron South , Senior Vice President , Chief Financial , Risk Factors , Supplemental Information , North American , Schein One , Shield Healthcare , North America ,